InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,166.40
(
0.51%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,210.14
(
0.31%
)
Post# of 252184
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119838
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rwwine post# 239979

Friday, 10/15/2021 7:19:26 PM

Friday, October 15, 2021 7:19:26 PM

Post# of 252184
Re: RVNC CRL

Daxi approval is now a late-2022/early-2023 event, at best. The additional wait is painful because RVNC’s cash burn is high, making another capital raise all but inevitable. For a biotech investor, today’s news is about as bad as it gets.

Nevertheless, I’m holding all of my shares because CMC problems are fixable and I’m confident Daxi will eventually be a big-selling drug. I’m not planning to add, at least for the time being.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up